Teachers Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
CCM
Teachers Advisors's CORT Position: Q1 2019 in Review
Teachers Advisors reduced its Corcept Therapeutics (CORT) stake by 32% in Q1 2019, selling an estimated $1.17M and leaving 200,353 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1888.
Teachers Advisors first reported a position in CORT in Q2 2013 and has held it in 24 quarters since. The position peaked at $17.2M in Q4 2017. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.
- Teachers Advisors held 200,353 shares of Corcept Therapeutics worth $2.35M as of Q1 2019.
- Teachers Advisors sold 94,410 Corcept Therapeutics shares in Q1 2019, an estimated $1.17M.
- Corcept Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1888 holding.
- Teachers Advisors first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 24 quarters since.
- Teachers Advisors's Corcept Therapeutics position peaked at $17.2M in Q4 2017.
- 208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.
Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.